European Biotech Acquisition Corp. (EBACW) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    European Biotech Acquisit...

    NASDAQ: EBACW · Real-Time Price · USD
    0.52
    -0.01 (-1.25%)
    At close: Mar 02, 2023, 9:56 PM

    European Biotech Acquisition Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a
    Cost of Revenue
    		 n/a n/a
    Gross Profit
    		 n/a n/a
    Operating Income
    		 -2.82M -1.1M
    Interest Income
    		 n/a n/a
    Pretax Income
    		 342.89K 1.48M
    Net Income
    		 3.5M 1.48M
    Selling & General & Admin
    		 2.79M 1.1M
    Research & Development
    		 n/a n/a
    Other Expenses
    		 32.94K n/a
    Operating Expenses
    		 2.82M 1.1M
    Interest Expense
    		 n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 2.82M 1.1M
    Income Tax Expense
    		 -3.16M n/a
    Shares Outstanding (Basic)
    		 12.76M 3.41M
    Shares Outstanding (Diluted)
    		 12.76M 13.66M
    EPS (Basic)
    		 0.27 0.43
    EPS (Diluted)
    		 0.27 0.11
    EBITDA
    		 -2.82M -3.68M
    EBIT
    		 n/a -1.1M
    Depreciation & Amortization
    		 -3.16M -2.58M

    Add to Watchlist